Comparative Effectiveness of Adding Alogliptin to Metformin Plus Sulfonylurea with Other DPP-4 Inhibitors in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis

INTRODUCTION: Alogliptin is an oral antihyperglycemic agent that is a selective inhibitor of the enzyme dipeptidyl peptidase-4 (DPP-4), approved for the treatment of type 2 diabetes mellitus (T2DM). There currently exists no comparative data to support the use of alogliptin in combination with metfo...

Descripción completa

Detalles Bibliográficos
Autores principales: Kay, Stephen, Strickson, Amanda, Puelles, Jorge, Selby, Ross, Benson, Eugene, Tolley, Keith
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5380505/
https://www.ncbi.nlm.nih.gov/pubmed/28275958
http://dx.doi.org/10.1007/s13300-017-0245-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5380505/
https://www.ncbi.nlm.nih.gov/pubmed/28275958
http://dx.doi.org/10.1007/s13300-017-0245-8

Ejemplares similares